Tacrolimus ointment is effective for psoriasis on the face and intertriginous areas in pediatric patients

Pediatric Dermatology

Volumn 24, Issue 1, 2007, Pages 76-80

  Brune, Adriana ^b   Miller, Drew W ^b   Lin, Peggy ^b   Cotrim Russi, Daniela ^b   Paller, Amy S ^a,b  

^a Department of Dermatology ^*  (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLECALCIFEROL; CORTICOSTEROID; RETINOID; TACROLIMUS;

ACNE; ADOLESCENT; ARTICLE; BURNING SENSATION; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DESQUAMATION; DISEASE SEVERITY; DRUG WITHDRAWAL; ERYTHEMA; FEMALE; HEAT SENSATION; HUMAN; MALE; OPEN STUDY; PEDIATRICS; PRIORITY JOURNAL; PRURITUS; PSORIASIS; RATING SCALE; SIDE EFFECT; SKIN IRRITATION; STATISTICAL SIGNIFICANCE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FACIAL DERMATOSES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERTRIGO; MALE; OINTMENTS; PILOT PROJECTS; PROSPECTIVE STUDIES; PSORIASIS; TACROLIMUS; TREATMENT OUTCOME;

EID: 33846960746     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2007.00341.x     Document Type: Article

References (14)

1. Trozak DJ. Topical corticosteroid therapy in psoriasis vulgaris: update and new strategies. Cutis 1999;64:315-318.
2. Chaffman MO. Topical corticosteroids: a review of properties and principles in therapeutic use. Nurse Pract Forum 1999;10:95-105.
3. Lebwohl MG, Tan MH, Meador SL, et al. Limited application of fluticasone propionate ointment, 0.005% in patients with psoriasis of the face and intertriginous areas. J Am Acad Dermatol 2001;44:77-82.
4. Peters BP, Weissman FG, Gill MA. Pathophysiology and treatment of psoriasis. Am J Health Syst Pharm 2000;57:645-659.
5. Ruzicka T, Bieber T, Schopf E, et al. A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group. N Engl J Med 1997;337:816-821.
6. Paller A, Eichenfield LF, Leung DY, et al. A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients. J Am Acad Dermatol 2001;44:S47-S57.
7. Zonneveld IM, Rubins A, Jablonska S, et al. Topical tacrolimus is not effective in chronic plaque psoriasis. Arch Dermatol 1998;134:1101-1102.
8. Scheinfeld N. The use of topical tacrolimus and pimecrolimus to treat psoriasis: a review. Dermatol Online J 2004;10:3.
9. Lebwohl M, Freeman AK, Chapman MS, et al. Tacrolimus ointment is effective for facial and intertriginous psoriasis. J Am Acad Dermatol 2004;51:723-730.
10. Freeman AK, Linowski GJ, Brady C, et al. Tacrolimus ointment for the treatment of psoriasis on the face and intertriginous areas. J Am Acad Dermatol 2003;48:564-568.
11. Yamamoto T, Nishioka K. Topical tacrolimus: an effective therapy for facial psoriasis. Eur J Dermatol 2003;13:471-473.
12. Yamamoto T, Nishioka K. Topical tacrolimus is effective for facial lesions of psoriasis. Acta Derm Venereol 2000;80:451.
13. Clayton TH, Harrison PV, Nicholls R, et al. Topical tacrolimus for facial psoriasis. Br J Dermatol 2003;149:419-420.
14. Fonacier L, Spergel J, Charlesworth EN, et al. Report of the Topical Calcineurin Inhibitor Task Force of the American College of Allergy, Asthma and Immunology and the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol 2005;115:1249-1253.